CLPHY(CLPHY)
CLPHY
No analyst ratings available
No analyst price targets available for CLPHY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $88.32B | $90.23B | $91.43B |
| Low | $85.94B | $82.25B | $86.14B |
| High | $90.38B | $94.24B | $94.54B |
| EBITDA Avg | $29.77B | $30.41B | $30.82B |
| Low | $28.97B | $27.72B | $29.03B |
| High | $30.46B | $31.76B | $31.86B |
| EBIT Avg | $19.74B | $20.17B | $20.44B |
| Low | $19.21B | $18.38B | $19.25B |
| High | $20.20B | $21.06B | $21.13B |
| Net Income Avg | $11.81B | $12.19B | $12.73B |
| Low | $10.92B | $11.27B | $11.77B |
| High | $12.33B | $12.72B | $13.29B |
| EPS Avg | $4.68 | $4.82 | $5.04 |
| Low | $4.32 | $4.46 | $4.66 |
| High | $4.88 | $5.04 | $5.26 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 5 / 1 |